MOGCT can lead to elevated tumor markers in peripheral blood, including AFP, β-hCG and LDH [1], although there are many factors affecting these tumor markers, However, it can still have a great auxiliary role in our diagnostic screening, treatment effect evaluation and early detection of recurrent cancer. This evidence concerns the gene AFP and cancer.